The current cost has been a "a real barrier to access and affordability," a rep for Novo Nordisk says in a statement to PEOPLE The maker of Wegovy and Ozempic announced that they're slashing prices of ...

Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...

If you have type 2 diabetes, your health care provider may recommend Victoza (liraglutide) or Ozempic (semaglutide) to help ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.

Canadian patients with private coverage using an Ozempic® Savings Card - as well as those paying entirely out-of-pocket - will now get Ozempic® (semaglutide) at a price aligned with generic ...

Australia could soon have a cheaper, needle-free alternative to Ozempic, with a weight-loss pill tipped for approval by ...

Novo Nordisk announced it will cut Wegovy and Ozempic list prices by up to 50% starting next year. (Dhiraj Singh/Bloomberg via Getty Images) Novo Nordisk on Tuesday announced plans to cut the list ...